Inhibitory Antibodies
-
F1539 Anti-NOTCH3 Antibody (Tarextumab)Summary: Anti-NOTCH3 Antibody (Tarextumab) -
F1540 Anti-DLL4 Antibody (Navicixizumab)Summary: Anti-DLL4 Antibody (Navicixizumab) -
F1541 Anti-Alpha-synuclein Antibody (Cinpanemab)Summary: Anti-Alpha-synuclein Antibody (Cinpanemab) -
F1542 Anti-DLL4 Antibody (Demcizumab)Summary: Anti-DLL4 Antibody (Demcizumab) -
F1543 Anti-DLL4 Antibody (Enoticumab)Summary: Anti-DLL4 Antibody (Enoticumab) -
F1544 Anti-Alpha-synuclein Antibody (Prasinezumab)Summary: Anti-Alpha-synuclein Antibody (Prasinezumab) -
F1545 Anti-DLL3 Antibody (Rovalpituzumab)Summary: Anti-DLL3 Antibody (Rovalpituzumab) -
F1546 Anti-Tau Antibody (Bepranemab)Summary: Anti-Tau Antibody (Bepranemab) -
F1547 Anti-Tau Antibody (Tilavonemab)Summary: Anti-Tau Antibody (Tilavonemab) -
F1548 Anti-NOTCH1 Antibody (Brontictuzumab)Summary: Anti-NOTCH1 Antibody (Brontictuzumab)